| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375 |
| filingDate |
2001-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2db6d0d75f24e768692869f9cddb04ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bed3c08cbd80264b71714bd86d439be |
| publicationDate |
2004-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004034106-A1 |
| titleOfInvention |
Treatment of anxiety disorders |
| abstract |
Selective norepinephrine reuptake inhibitors are used to treat anxiety disorders, especially obsessive-compulsive disorder. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10933073-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471439-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018148605-A1 |
| priorityDate |
2001-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |